Oxytetracycline Product Promises Timely Relief From HLB

Josh McGillHLB Management

What may be the closest thing yet to a timely silver bullet for HLB was discussed Oct. 26 at Lake Alfred’s Citrus Research and Education Center. Josh Steinbronn, director of research and development at TJ BioTech, said trunk injection of his company’s ReMedium TI oxytetracycline product suppresses Candidatus Liberibacter asiaticus (CLas), the causal agent of HLB. He added that injection …

Two New Tools in the Fight Against HLB Seek EPA Registration

Josh McGillHLB Management

The recent Florida Citrus Industry Annual Conference featured educational presentations on navigating production in an environment where HLB is endemic in groves. Two of those presentations focused on new technology being developed for use in citrus. Two companies, Elemental Enzymes and TJ BioTech, have been collaborating with the Citrus Research and Development Foundation (CRDF) to research their respective products’ potential …